ARMS is dedicated to advancing unique research that will make a difference in the lives of people with multiple sclerosis.
Concerned about the lack of almost any research about progressive stages of MS, our board members met with MS researchers at the University at Buffalo’s during the summer of 2013. We asked them to examine how MS affects people over 60. In response to our meeting, they developed a unique study that is examining how disease progression is affected by lifestyle, various drug therapies, genes, environment, and age.
What is unique about this study? To date, no MS research has put together in one study the factors of age, lifestyle, drug therapies, genetics, and environment.
The study will be directed by renowned MS researcher and clinician, Bianca Weinstock-Guttman, MD.
She will collaborate with University at Buffalo colleagues Robert Zivadinov, MD, PhD, FAAN; Ralph Benedict, PhD; and Murali Ramanathan, PhD.
This work is part of a larger MS study under the direction of Dr. Zivadinov and has been approved by the university’s Internal Review Board.
For questions about this study or its parent study, contact ARMS at [email protected].
If you would like to have a voice in shaping future MS research studies like this one, we encourage you to become a member of our organization today. It's free!
To find out more, visit our membership page.
Bianca Weinstock-Guttman, MD
Professor of Neurology
State University of New York at Buffalo
Director, Jacobs MS Center for Treatment & Research
Director, Jacobs Pediatric MS Center of Excellence
Executive Director, NY State MS Consortium